InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the complete record of transactions filed by Josephs Paul. Director active across 1 company, notably LIFECORE BIOMEDICAL, INC. \DE\. Aggregated, 5 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €94k. Activity tracked since 6 December 2024. The latest transaction was filed on 20 May 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Josephs Paul is a declarant linked to LIFECORE BIOMEDICAL, INC. \DE\, where he is Chief Executive Officer. He has 5 filings in total, and across the 5 sampled filings between 2024-05-22 and 2025-07-10, the reported buy volume is EUR 94321 and the sell volume is EUR 0; the modal transaction nature is Attribution.